Psychiatric Treatment of Persons With HIV/AIDS: An HIV-Psychiatry Consensus Survey of Current Practices
Tài liệu tham khảo
Adewuya, 2007, Psychiatric disorders among the HIV-positive population in Nigeria: a control study, J Psychosom Res, 63, 203, 10.1016/j.jpsychores.2007.03.006
Bing, 2001, Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States, Arch Gen Psychiatry, 58, 721, 10.1001/archpsyc.58.8.721
Petrushkin, 2005, Psychiatric disorders in HIV-positive individuals in urban Uganda, Psychiatr Bull, 29, 455, 10.1192/pb.29.12.455
Wormser, 2004, AIDS and other manifestations of HIV infection
Horberg, 2008, Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients, J Acquir Immune Defic Syndr, 47, 384, 10.1097/QAI.0b013e318160d53e
Leserman, 2008, Role of depression, stress, and trauma in HIV disease progression, Psychosom Med, 70, 539, 10.1097/PSY.0b013e3181777a5f
Olatunji, 2006, Review of treatment studies of depression in HIV, Topics in HIV Med, 14, 112
2006
2008
American Psychiatric Association: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_4.aspx. (last accessed 05/08/09)
Breitbart, 1996, A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients, Am J Psychiatry, 153, 231, 10.1176/ajp.153.2.231
Breitbart, 2001, A randomized, doubleblind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease, Arch Intern Med, 161, 411, 10.1001/archinte.161.3.411
Elliott, 1998, Randomized, placebocontrolled trial of paroxetine versus imipramine in depressed HIV-positive outpatients, Am J Psychiatry, 155, 367
Rabkin, 1999, Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial, Am J Psychiatry, 156, 101, 10.1176/ajp.156.1.101
Rabkin, 2004, Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial, J Clin Psychopharmacol, 24, 379, 10.1097/01.jcp.0000132442.35478.3c
Rabkin, 2006, Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS, Am J Psychiatry, 163, 59, 10.1176/appi.ajp.163.1.59
Wagner, 2000, Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebocontrolled trial, J Clin Psychiatry, 61, 436, 10.4088/JCP.v61n0608
Expert Consensus Guidelines: http://www.psychguides.com/schizophrenia. (last accessed 05/08/09)
Wynn, 2004, Antiretrovirals, part 1: overview, history, and focus on protease inhibitors, Psychosomatics, 45, 262, 10.1176/appi.psy.45.3.262
Zapor, 2004, Antiretrovirals, part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors), Psychosomatics, 45, 524, 10.1176/appi.psy.45.6.524
Sandson, 2005, An overview of psychotropic drug– drug interactions, Psychosomatics, 46, 464, 10.1176/appi.psy.46.5.464
Omonuwa, 2009, The pharmacologic management of insomnia in patients with HIV, J Clin Sleep Med, 5, 251, 10.5664/jcsm.27496
Wynn GH, Oesterheld JR, Cozza KL, et al: Clinical Manual of Drug Interaction Principles for Medical Practice: Oesterheld JR: 3A4. Washington, DC, American Psychiatric Press, 2009, pp 111–112
Juncos, 2004, Quetiapine improves psychotic symptoms and cognition in Parkinson’s disease, Mov Disord, 19, 29, 10.1002/mds.10620
Kumar, 2007, Human immunodeficiency virus type 1: RNA levels in different regions of human brain: quantification using real-time reverse transcriptasepolymerase chain reaction, J Neurovirol, 13, 210, 10.1080/13550280701327038
Menza, 1987, Decreased extrapyramidal symptoms with intravenous haloperidol, J Clin Psychiatry, 48, 278
Ayuso, 1994, Use of psychotropic drugs in patients with HIV infection, Drugs, 47, 599, 10.2165/00003495-199447040-00004
Romanelli, 2000, Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals, Neurology, 54, 1404, 10.1212/WNL.54.7.1404
Cozza, 2000, Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: a case report, Psychosomatics, 41, 452, 10.1176/appi.psy.41.5.452
Stahl, 2009, Which comes first: atypical antipsychotic treatment or cardiometabolic risk?, Acta Psychiatr Scand, 119, 171, 10.1111/j.1600-0447.2008.01334.x
Ballard, 2009, The dementia antipsychotic withdrawal trial (DART–AD): long-term follow-up of a randomised, placebo-controlled trial, Lancet Neurol, 8, 151, 10.1016/S1474-4422(08)70295-3
Safren, 2009, A randomized, controlled trial of cognitive-behavioral therapy for adherence and depression (CBT–AD) in HIV-infected individuals, Health Psychol, 28, 1, 10.1037/a0012715
Fremont, 2008, Comfort level of pediatricians and family-medicine physicians diagnosing and treating child and adolescent psychiatric disorders, Int J Psychiatry Med, 38, 153, 10.2190/PM.38.2.c
Scholz, 2009, Peripheral nerve injuries: an international survey of current treatments and future perspectives, J Reconstr Microsurg, 25, 339, 10.1055/s-0029-1215529
Reid, 2006, Insomnia in HIV infection: a systematic review of prevalence, correlates, and management, Psychosom Med, 67, 260, 10.1097/01.psy.0000151771.46127.df
Douaihy, 2007, Psychiatric aspects of comorbid HIV/AIDS and pain, part 1, AIDS Read, 17, 310
Paddison, 2009, Fatigue in psychiatric HIV patients: a pilot study of psychological correlates, Psychosomatics, 455, 10.1016/S0033-3182(09)70837-0
Sacktor, 2001, HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998, Neurology, 56, 257, 10.1212/WNL.56.2.257
Nejad, 2009, Clozapine use in HIVinfected schizophrenia patients: a case-based discussion, Psychosomatics, 626, 10.1016/S0033-3182(09)70866-7
Lera, 1999, Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism, Mov Disord, 14, 128, 10.1002/1531-8257(199901)14:1<128::AID-MDS1021>3.0.CO;2-J
Fincham, 2008, Response rates and responsiveness for surveys, standards, and the journal, Am J Pharm Educ, 72, 1, 10.5688/aj720243